Live Breaking News & Updates on Gene Division

Stay updated with breaking news from Gene division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lonza : Two Cell and Gene Therapies Manufactured at Lonza Houston Reach US FDA Approval in Q3 2022

Basel, Switzerland, Thursday 6 October 2022 - Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutrition industries, today announced that two additional cell. | October 6, 2022 ....

United States , Alberto Santagostino , Gene Division , Drug Administration , Rgene Technologies , Lonza Group Ag Stock Exchange , Press Release , Dditional Lonn Ch0013841017 ,